TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Healius Limited ( (AU:HLS) ) has shared an update.
Healius Limited has announced a change in the director’s interest, with Paul Anderson acquiring an additional 54,431 ordinary shares through an on-market trade. This change reflects an increase in Anderson’s indirect interest in the company, potentially signaling confidence in Healius’s future performance and impacting stakeholder perceptions positively.
The most recent analyst rating on (AU:HLS) stock is a Hold with a A$1.00 price target. To see the full list of analyst forecasts on Healius Limited stock, see the AU:HLS Stock Forecast page.
More about Healius Limited
Healius Limited operates in the healthcare industry, providing medical services and facilities across Australia. The company focuses on offering pathology services, diagnostic imaging, and day hospital services, catering to a broad market that includes individual patients, healthcare providers, and government entities.
Average Trading Volume: 4,429,646
Technical Sentiment Signal: Sell
Current Market Cap: A$646.3M
See more data about HLS stock on TipRanks’ Stock Analysis page.